Citadel Advisors’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $1.45B | Sell |
1,581,800
-507,000
| -24% | -$514M | 0.24% | 62 |
|
|
2025
Q4 | $2.24B | Sell |
2,088,800
-140,600
| -6% | -$134M | 0.34% | 46 |
|
|
2025
Q3 | $1.7B | Buy |
2,229,400
+508,900
| +30% | +$379M | 0.26% | 51 |
|
|
2025
Q2 | $1.34B | Buy |
1,720,500
+71,000
| +4% | +$55.2M | 0.23% | 50 |
|
|
2025
Q1 | $1.36B | Sell |
1,649,500
-207,200
| -11% | -$172M | 0.26% | 39 |
|
|
2024
Q4 | $1.43B | Buy |
1,856,700
+415,000
| +29% | +$344M | 0.25% | 41 |
|
|
2024
Q3 | $1.28B | Buy |
1,441,700
+249,500
| +21% | +$224M | 0.25% | 47 |
|
|
2024
Q2 | $1.08B | Sell |
1,192,200
-240,000
| -17% | -$192M | 0.22% | 52 |
|
|
2024
Q1 | $1.11B | Sell |
1,432,200
-162,500
| -10% | -$116M | 0.21% | 50 |
|
|
2023
Q4 | $930M | Buy |
1,594,700
+235,300
| +17% | +$137M | 0.19% | 52 |
|
|
2023
Q3 | $730M | Buy |
1,359,400
+44,900
| +3% | +$23.1M | 0.16% | 62 |
|
|
2023
Q2 | $616M | Buy |
1,314,500
+557,600
| +74% | +$234M | 0.13% | 78 |
|
|
2023
Q1 | $260M | Sell |
756,900
-614,800
| -45% | -$207M | 0.06% | 228 |
|
|
2022
Q4 | $502M | Sell |
1,371,700
-1,110,100
| -45% | -$394M | 0.12% | 104 |
|
|
2022
Q3 | $802M | Buy |
2,481,800
+1,629,100
| +191% | +$516M | 0.18% | 49 |
|
|
2022
Q2 | $276M | Sell |
852,700
-84,800
| -9% | -$25.5M | 0.07% | 190 |
|
|
2022
Q1 | $268M | Sell |
937,500
-37,200
| -4% | -$9.57M | 0.06% | 242 |
|
|
2021
Q4 | $269M | Sell |
974,700
-122,900
| -11% | -$31.2M | 0.06% | 248 |
|
|
2021
Q3 | $254M | Buy |
1,097,600
+3,100
| +0.3% | +$765K | 0.05% | 263 |
|
|
2021
Q2 | $251M | Buy |
1,094,500
+234,700
| +27% | +$47.1M | 0.06% | 248 |
|
|
2021
Q1 | $161M | Sell |
859,800
-121,900
| -12% | -$23.8M | 0.04% | 377 |
|
|
2020
Q4 | $166M | Buy |
981,700
+488,000
| +99% | +$72.9M | 0.04% | 328 |
|
|
2020
Q3 | $73.1M | Sell |
493,700
-177,900
| -26% | -$27.5M | 0.02% | 628 |
|
|
2020
Q2 | $110M | Sell |
671,600
-46,200
| -6% | -$7.09M | 0.04% | 359 |
|
|
2020
Q1 | $99.6M | Sell |
717,800
-156,400
| -18% | -$21.5M | 0.04% | 337 |
|
|
2019
Q4 | $115M | Buy |
874,200
+372,300
| +74% | +$43.2M | 0.05% | 339 |
|
|
2019
Q3 | $56.1M | Buy |
501,900
+151,500
| +43% | +$16.9M | 0.03% | 689 |
|
|
2019
Q2 | $38.8M | Sell |
350,400
-325,900
| -48% | -$38.4M | 0.02% | 894 |
|
|
2019
Q1 | $87.8M | Buy |
676,300
+47,700
| +8% | +$5.8M | 0.04% | 414 |
|
|
2018
Q4 | $72.7M | Buy |
628,600
+23,000
| +4% | +$2.57M | 0.04% | 455 |
|
|
2018
Q3 | $65M | Buy |
605,600
+389,800
| +181% | +$39M | 0.03% | 607 |
|
|
2018
Q2 | $18.4M | Sell |
215,800
-29,600
| -12% | -$2.43M | 0.01% | 1378 |
|
|
2018
Q1 | $19M | Sell |
245,400
-235,700
| -49% | -$19M | 0.01% | 1161 |
|
|
2017
Q4 | $40.6M | Buy |
481,100
+266,100
| +124% | +$22.6M | 0.02% | 736 |
|
|
2017
Q3 | $18.4M | Sell |
215,000
-50,000
| -19% | -$4.1M | 0.01% | 1121 |
|
|
2017
Q2 | $21.8M | Buy |
265,000
+11,700
| +5% | +$955K | 0.02% | 952 |
|
|
2017
Q1 | $21.3M | Sell |
253,300
-189,400
| -43% | -$15.2M | 0.02% | 912 |
|
|
2016
Q4 | $32.6M | Buy |
442,700
+34,200
| +8% | +$2.55M | 0.03% | 583 |
|
|
2016
Q3 | $32.8M | Buy |
408,500
+181,400
| +80% | +$14.5M | 0.03% | 596 |
|
|
2016
Q2 | $17.9M | Sell |
227,100
-32,400
| -12% | -$2.44M | 0.02% | 856 |
|
|
2016
Q1 | $18.7M | Buy |
259,500
+84,400
| +48% | +$6.39M | 0.02% | 785 |
|
|
2015
Q4 | $14.8M | Sell |
175,100
-65,700
| -27% | -$5.45M | 0.02% | 1016 |
|
|
2015
Q3 | $20.2M | Buy |
240,800
+65,300
| +37% | +$5.51M | 0.02% | 897 |
|
|
2015
Q2 | $14.7M | Sell |
175,500
-13,100
| -7% | -$998K | 0.01% | 1221 |
|
|
2015
Q1 | $13.7M | Buy |
188,600
+1,300
| +0.7% | +$92.6K | 0.01% | 1220 |
|
|
2014
Q4 | $12.9M | Buy |
187,300
+61,900
| +49% | +$4.18M | 0.01% | 1222 |
|
|
2014
Q3 | $8.13M | Sell |
125,400
-61,400
| -33% | -$3.89M | 0.01% | 1536 |
|
|
2014
Q2 | $11.6M | Sell |
186,800
-4,900
| -3% | -$292K | 0.01% | 1150 |
|
|
2014
Q1 | $11.3M | Sell |
191,700
-51,000
| -21% | -$2.85M | 0.01% | 1182 |
|
|
2013
Q4 | $12.4M | Sell |
242,700
-49,900
| -17% | -$2.5M | 0.02% | 1083 |
|
|
2013
Q3 | $14.7M | Buy |
292,600
+44,900
| +18% | +$2.35M | 0.02% | 878 |
|
|
2013
Q2 | $12.2M | Buy |
+247,700
| New | +$13.5M | 0.02% | 942 |
|
Other funds holding LLY
VCM
VPM
Citadel Advisors's LLY Position: Q1 2026 in Review
Citadel Advisors reduced its Eli Lilly (LLY) stake by 65% in Q1 2026, selling an estimated $464M and leaving 241,714 shares worth $222M. The position accounts for 0.04% of the portfolio, ranked #410.
Citadel Advisors first reported a position in LLY in Q2 2013 and has held it in 52 quarters since. The position peaked at $880M in Q3 2025. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.
- Citadel Advisors held 241,714 shares of Eli Lilly worth $222M as of Q1 2026.
- Citadel Advisors sold 458,045 Eli Lilly shares in Q1 2026, an estimated $464M.
- Eli Lilly made up 0.04% of Citadel Advisors's portfolio in Q1 2026, its #410 holding.
- Citadel Advisors first reported a position in Eli Lilly in Q2 2013 and has held it in 52 quarters since.
- Citadel Advisors's Eli Lilly position peaked at $880M in Q3 2025.
- 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.
Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.